KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Bionano Genomics (BNGO) Leases (2021 - 2025)

Bionano Genomics' Leases history spans 5 years, with the latest figure at $3.1 million for Q3 2025.

  • For Q3 2025, Leases rose 11.05% year-over-year to $3.1 million; the TTM value through Sep 2025 reached $3.1 million, up 11.05%, while the annual FY2024 figure was $1.8 million, 67.97% down from the prior year.
  • Leases for Q3 2025 was $3.1 million at Bionano Genomics, down from $3.2 million in the prior quarter.
  • Across five years, Leases topped out at $7.2 million in Q4 2022 and bottomed at $1.8 million in Q4 2024.
  • The 5-year median for Leases is $3.9 million (2021), against an average of $4.5 million.
  • The largest annual shift saw Leases surged 83.95% in 2022 before it crashed 67.97% in 2024.
  • A 5-year view of Leases shows it stood at $3.9 million in 2021, then soared by 83.95% to $7.2 million in 2022, then decreased by 22.0% to $5.6 million in 2023, then plummeted by 67.97% to $1.8 million in 2024, then surged by 74.39% to $3.1 million in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Leases are $3.1 million (Q3 2025), $3.2 million (Q2 2025), and $3.2 million (Q1 2025).